secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001193125-25-227025
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio appoints Susan Altschuller as CFO, grants 600,000 stock options
-------------------------------------------------------------------------

- Appointed Susan Altschuller, Ph.D., MBA, as CFO and Treasurer effective Oct 1, 2025; previously CFO at Cerevel and ImmunoGen.
- Base salary $510,000/year; eligible for annual bonus up to 40% of base.
- Received option to purchase 600,000 shares under 2025 Inducement Plan; vesting 25% on one-year anniversary then monthly.
- Board amended Inducement Plan to increase reserved shares from 1.25M to 2.0M.
- Cindy Driscoll steps down as principal financial officer but continues as principal accounting officer.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/0001193125-25-227025-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525227025/d33819d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-227025

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer